UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

The Presence of an FKS Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata

Antimicrobial Agents and Chemotherapy, 2012-09, Vol.56 (9), p.4862-4869

2012

Link zum Volltext

Verfügbarkeit prüfen

Nebulized Colistin in the Treatment of Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa

Clinical infectious diseases, 2005-09, Vol.41 (5), p.754-757

2005

Link zum Volltext

Verfügbarkeit prüfen

First report of environmental bla PAC-1 -carrying Aeromonas enteropelogenes

Microbiology spectrum, 2023-12, Vol.11 (6), p.e0139123-e0139123

2023

Link zum Volltext

Verfügbarkeit prüfen

In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore

PloS one, 2011-04, Vol.6 (4), p.e18485-e18485

2011

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of Appropriate Empiric Combination versus Monotherapy for Pseudomonas aeruginosa Bacteremia

Antimicrobial Agents and Chemotherapy, 2013-03, Vol.57 (3), p.1270-1274

2013

Link zum Volltext

Verfügbarkeit prüfen

Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B

PloS one, 2011-12, Vol.6 (12), p.e28177

2011

Link zum Volltext

Verfügbarkeit prüfen

Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients

CPT: pharmacometrics and systems pharmacology, 2021-12, Vol.10 (12), p.1525-1537

2021

Link zum Volltext

Verfügbarkeit prüfen

From Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)

PloS one, 2016-07, Vol.11 (7), p.e0158740-e0158740

2016

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2005-09, Vol.49 (9), p.3624-3630

2005

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of Polymyxin B in a Patient With Renal Insufficiency: A Case Report

Clinical infectious diseases, 2011-05, Vol.52 (10), p.1280-1281

2011

Link zum Volltext

Verfügbarkeit prüfen

Predictors and Outcomes of Healthcare-Associated Infections Caused by Carbapenem-Nonsusceptible Enterobacterales: A Parallel Matched Case-Control Study

Frontiers in cellular and infection microbiology, 2022-02, Vol.12, p.719421-719421

2022

Link zum Volltext

Verfügbarkeit prüfen

Polymyxin B versus colistin: an update

Expert review of anti-infective therapy, 2015-12, Vol.13 (12), p.1481-1497

2015

Link zum Volltext

Verfügbarkeit prüfen

Stemming the Rise of Antibiotic Use for Community-Acquired Acute Respiratory Infections during COVID-19 Pandemic

Antibiotics (Basel), 2022-06, Vol.11 (7), p.846

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections—A Cohort Study

Antibiotics (Basel), 2020-08, Vol.9 (8), p.451

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales

Frontiers in cellular and infection microbiology, 2020-10, Vol.10, p.579462-579462

2020

Link zum Volltext

Verfügbarkeit prüfen

Estimating the economic cost of carbapenem resistant Enterobacterales healthcare associated infections in Singapore acute-care hospitals

PLOS global public health, 2022, Vol.2 (12), p.e0001311-e0001311

2022

Link zum Volltext

Verfügbarkeit prüfen

Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study

International journal of antimicrobial agents, 2021-06, Vol.57 (6), p.106340-106340, Article 106340

2021

Link zum Volltext

Verfügbarkeit prüfen

Elimination of Extracellular Adenosine Triphosphate for the Rapid Prediction of Quantitative Plate Counts in 24 h Time-Kill Studies against Carbapenem-Resistant Gram-Negative Bacteria

Microorganisms (Basel), 2020-09, Vol.8 (10), p.1489

2020

Link zum Volltext

Verfügbarkeit prüfen

Estimating the excess bed days and economic burden of healthcare-associated infections in Singapore public acute-care hospitals

Infection control and hospital epidemiology, 2022-09, Vol.43 (9), p.1245-1248

2022

Link zum Volltext

Verfügbarkeit prüfen

Performance of Population Pharmacokinetic Models in Predicting Polymyxin B Exposures

Microorganisms (Basel), 2020-11, Vol.8 (11), p.1814

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for extreme-drug resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies

American journal of infection control, 2013-02, Vol.41 (2), p.140-144

2013

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore

Journal of antibiotics, 2009-12, Vol.62 (12), p.675-679

2009

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Assessment of Combination Antimicrobial Therapy against Multidrug-Resistant Acinetobacter baumannii

Antimicrobial Agents and Chemotherapy, 2008-08, Vol.52 (8), p.2898-2904

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(86)
Mit Volltextzugriff
(91)

Publikationsform

Artikel
(91)
Berichte
(3)

Sprache

Englisch
(94)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Life Sciences & Biomedicine
(60)
Humans
(42)
Infectious Diseases
(37)
Microbiology
(36)
Pharmacology & Pharmacy
(24)
Male
(22)
Middle Aged
(18)
Female
(17)
Adult
(15)
Aged
(15)
Antibiotics
(15)
Anti-Bacterial Agents - Pharmacology
(14)
Microbial Sensitivity Tests
(13)
Polymyxin B
(13)
Pseudomonas Aeruginosa
(13)
Anti-Bacterial Agents - Therapeutic Use
(12)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Immunology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Presence of an FKS Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata

Prevalence of Healthcare-Associated Infections and Antimicrobial Use Among Adult Inpatients in Singapore Acute-Care Hospitals: Results From the First National Point Prevalence Survey

The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive Klebsiella pneumoniae in a Multi-Country Collection

Nebulized Colistin in the Treatment of Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa

First report of environmental bla PAC-1 -carrying Aeromonas enteropelogenes

In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore

Outcomes of Appropriate Empiric Combination versus Monotherapy for Pseudomonas aeruginosa Bacteremia

Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B

Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients

From Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)

Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa

Pharmacokinetics of Polymyxin B in a Patient With Renal Insufficiency: A Case Report

Predictors and Outcomes of Healthcare-Associated Infections Caused by Carbapenem-Nonsusceptible Enterobacterales: A Parallel Matched Case-Control Study

Polymyxin B versus colistin: an update

Stemming the Rise of Antibiotic Use for Community-Acquired Acute Respiratory Infections during COVID-19 Pandemic

Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections—A Cohort Study

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales

Estimating the economic cost of carbapenem resistant Enterobacterales healthcare associated infections in Singapore acute-care hospitals

Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study

Elimination of Extracellular Adenosine Triphosphate for the Rapid Prediction of Quantitative Plate Counts in 24 h Time-Kill Studies against Carbapenem-Resistant Gram-Negative Bacteria

Estimating the excess bed days and economic burden of healthcare-associated infections in Singapore public acute-care hospitals

Performance of Population Pharmacokinetic Models in Predicting Polymyxin B Exposures

Risk factors for extreme-drug resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies

In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore

Quantitative Assessment of Combination Antimicrobial Therapy against Multidrug-Resistant Acinetobacter baumannii

Suchergebnisse filtern